TP53 and neoplasm: However, as reviewed by Jiang et al., asparagine depletion further reduces the transcription of ASNS in a feedforward manner via p53 activation in tumor cells, warranting further studies on the role of p53 mutations in determining the efficacy of L-asparaginase therapy (113).